As Figure 3C–3D show, Cyp1A2 siRNA consistently prevented an induction of both VEGF mRNA and protein by erlotinib in HCC-1.2 and HCC-3 cells. This evidence concerns the gene VEGFA and hepatocellular carcinoma.